News & Blogs

American patients shouldn’t foot the bill for the world’s medicines

Heading into November, voters rank healthcare costs as their single biggest economic worry. For the first time since Kaiser Family Foundation began tracking the question in 2018, a majority now say they’re specifically anxious about affording their prescriptions. And right now, voters trust Democrats more than Republicans to do something about it, by roughly 12 points, and by a similar margin on drug affordability specifically.

Republicans can close that gap. We have the ideas that actually work, such as transparency and free-market competition rather than Washington price-setting, and trade leverage instead of surrendering to foreign governments that have spent decades exploiting American drug innovation.